Literature DB >> 22257522

Don't pick the loser: lessons from the GeparQuinto trial.

Stephen K Chia1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22257522     DOI： 10.1016/S1470-2045(12)70013-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  Breast cancer: Neoadjuvant bevacizumab treatment-signal or noise?

Authors:  Harold J Burstein
Journal:  Nat Rev Clin Oncol       Date:  2012-03-13       Impact factor: 66.675
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.